MedPath
NMPA Approval

Regorafenib Tablets

国药准字H20249282

November 5, 2024

Drug Information

瑞戈非尼片

片剂

40mg

化学药品

November 5, 2024

Company Information

Applicant Company

重庆市渝北区人和镇星光大道100号

Manufacturing Company

重庆市北碚区京东方大道66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞戈非尼片 - NMPA 批准文号 | MedPath